Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K/A
2022 FY
Annual report (amended)
13 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
28 Mar 24
8-K
Departure of Directors or Certain Officers
14 Feb 24
8-K
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023
9 Nov 23
8-K
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
10 Aug 23
8-K
Arcadia Biosciences (RKDA) Announces Strategic Review
20 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
8-K
Arcadia Biosciences (RKDA) Announces First Quarter 2023
11 May 23
8-K
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights
30 Mar 23
8-K
Entry into a Material Definitive Agreement
3 Mar 23
8-K
Material Modifications to Rights of Security Holders
28 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
25 May 23
424B3
Prospectus supplement
17 Apr 23
S-3
Shelf registration
3 Apr 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
8-A12G
Registration of securities
8 Dec 22
424B3
Prospectus supplement
7 Oct 22
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 23
DEF 14A
Definitive proxy
25 Apr 23
DEF 14A
Definitive proxy
6 Jan 23
PRE 14A
Preliminary proxy
23 Dec 22
DEFA14A
Additional proxy soliciting materials
19 Apr 22
DEF 14A
Definitive proxy
19 Apr 22
DEFA14A
Additional proxy soliciting materials
16 Jun 21
DEFA14A
Additional proxy soliciting materials
7 Jun 21
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DEF 14A
Definitive proxy
20 Apr 21
Other
EFFECT
Notice of effectiveness
18 Apr 23
CORRESP
Correspondence with SEC
13 Apr 23
UPLOAD
Letter from SEC
10 Apr 23
CORRESP
Correspondence with SEC
3 Apr 23
EFFECT
Notice of effectiveness
6 Oct 22
CORRESP
Correspondence with SEC
4 Oct 22
UPLOAD
Letter from SEC
3 Oct 22
EFFECT
Notice of effectiveness
13 May 22
CORRESP
Correspondence with SEC
10 May 22
UPLOAD
Letter from SEC
27 Apr 22
Ownership
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Thomas J. Schaefer
5 Feb 24
SC 13G
SABBY MANAGEMENT, LLC
3 Jan 24
4
Thomas J. Schaefer
7 Aug 23
4
Deborah D Carosella
16 Jun 23
4
Amy Yoder
16 Jun 23
4
Albert D. Bolles
16 Jun 23
4
GREGORY D WALLER
16 Jun 23
4
Lilian Shackelford Murray
16 Jun 23
4
Kevin Comcowich
16 Jun 23